Blueprint Investment Partners LLC reduced its stake in shares of Agilent Technologies, Inc. (NYSE: A – Get Rating) by 30.9% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,757 shares of the medical research company stock after selling 787 shares during the quarter. Blueprint Investment Partners LLC’s holdings in Agilent Technologies were worth $ 281,000 as of its most recent SEC filing.
Other large investors have also made changes to their positions in the company. EverSource Wealth Advisors LLC acquired a new position in Agilent Technologies during the 4th quarter valued at about $ 31,000. Glassman Wealth Services increased its holdings in shares of Agilent Technologies by 47.4% in the fourth quarter. Glassman Wealth Services now owns 230 shares of the medical research company stock valued at $ 37,000 after purchasing an additional 74 shares during the period. Larson Financial Group LLC acquired a new position in shares of Agilent Technologies in the fourth quarter valued at about $ 39,000. CVA Family Office LLC acquired a new position in shares of Agilent Technologies in the fourth quarter valued at about $ 41,000. Finally, Asset Dedication LLC acquired a new position in shares of Agilent Technologies in the fourth quarter valued at about $ 42,000.
In other news, SVP Michael Tang sold 1,210 shares of the firm’s stock in a transaction on Friday, March 18th. The stock was sold at an average price of $ 136.21, for a total transaction of $ 164,814.10. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, VP Jacob Thaysen sold 5,879 shares of the business’s stock in a transaction on Thursday, June 2nd. The shares were sold at an average price of $ 127.43, for a total value of $ 749,160.97. Following the completion of the sale, the vice president now owns 88,737 shares in the company, valued at approximately $ 11,307,755.91. The disclosure for this sale can be found here.
A number of brokerages have recently weighed in on A. Wells Fargo & Company cut their price objective on Agilent Technologies from $ 160.00 to $ 130.00 and set an “equal weight” rating on the stock in a report on Monday, April 25th. Stifel Nicolaus dropped their target price on Agilent Technologies from $ 169.00 to $ 145.00 and set a “hold” rating on the stock in a report on Wednesday, February 23rd. Citigroup dropped their target price on Agilent Technologies from $ 190.00 to $ 175.00 and set a “buy” rating on the stock in a report on Wednesday, February 23rd. KeyCorp dropped their target price on Agilent Technologies from $ 195.00 to $ 155.00 and set an “overweight” rating on the stock in a report on Thursday, June 2nd. Finally, Robert W. Baird raised their target price on Agilent Technologies from $ 155.00 to $ 161.00 and gave the stock an “outperform” rating in a report on Wednesday, May 25th. Three analysts have rated the stock with a hold rating, ten have issued a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Buy” and an average target price of $ 159.91.
Shares of A opened at $ 120.57 on Monday. The stock has a 50 day moving average price of $ 124.55 and a 200 day moving average price of $ 136.11. The stock has a market capitalization of $ 36.02 billion, a price-to-earnings ratio of 29.05, a PEG ratio of 2.46 and a beta of 1.05. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.49 and a current ratio of 2.01. Agilent Technologies, Inc. has a one year low of $ 112.64 and a one year high of $ 179.57.
Agilent Technologies (NYSE: A – Get Rating) last issued its earnings results on Tuesday, May 24th. The medical research company reported $ 1.13 EPS for the quarter, topping analysts’ consensus estimates of $ 1.12 by $ 0.01. Agilent Technologies had a net margin of 19.35% and a return on equity of 27.42%. The company had revenue of $ 1.61 billion for the quarter, compared to the consensus estimate of $ 1.62 billion. During the same period in the previous year, the firm earned $ 0.97 earnings per share. Agilent Technologies’s quarterly revenue was up 5.4% compared to the same quarter last year. On average, analysts predict that Agilent Technologies, Inc. will post 4.9 earnings per share for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 27th. Investors of record on Tuesday, July 5th will be issued a $ 0.21 dividend. The ex-dividend date is Friday, July 1st. This represents a $ 0.84 annualized dividend and a yield of 0.70%. Agilent Technologies’s dividend payout ratio (DPR) is currently 20.24%.
Agilent Technologies Company Profile: (Get Rating)
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies.
Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE: A – Get Rating).
Receive News & Ratings for Agilent Technologies Daily: – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Agilent Technologies and related companies with MarketBeat.com’s FREE daily email newsletter.